KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $107.7 million.

  • Novavax's Other Non-Current Assets rose 25245.03% to $107.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.7 million, marking a year-over-year increase of 25245.03%. This contributed to the annual value of $24.0 million for FY2024, which is 3173.87% down from last year.
  • Novavax's Other Non-Current Assets amounted to $107.7 million in Q3 2025, which was up 25245.03% from $21.4 million recorded in Q2 2025.
  • Over the past 5 years, Novavax's Other Non-Current Assets peaked at $107.7 million during Q3 2025, and registered a low of $17.4 million during Q3 2022.
  • For the 5-year period, Novavax's Other Non-Current Assets averaged around $32.8 million, with its median value being $30.5 million (2024).
  • Per our database at Business Quant, Novavax's Other Non-Current Assets skyrocketed by 38450.68% in 2021 and then tumbled by 5460.09% in 2022.
  • Quarter analysis of 5 years shows Novavax's Other Non-Current Assets stood at $24.3 million in 2021, then grew by 17.2% to $28.5 million in 2022, then rose by 23.5% to $35.2 million in 2023, then plummeted by 31.74% to $24.0 million in 2024, then soared by 348.6% to $107.7 million in 2025.
  • Its last three reported values are $107.7 million in Q3 2025, $21.4 million for Q2 2025, and $21.9 million during Q1 2025.